Financials
- Market Capitalization 3.61 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
41.95
市销率
8.46
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1560 | DNLI Denali Therapeutics Inc. - Common Stock | 22.85 USD | -1.80% | -6.47% | -2.97% | +41.31% | 3.65 B USD | ||
| 1564 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 82.76 USD | +11.76% | +18.11% | +34.20% | +25.28% | 3.63 B USD | ||
| 1599 | ABCL AbCellera Biologics Inc. - Common Shares | 11.47 USD | +0.97% | -6.21% | +92.13% | +187.47% | 3.52 B USD | ||
| 1613 | GPCR Structure Therapeutics Inc - American Depositary Shares | 47.80 USD | +1.42% | -3.65% | -3.24% | +78.76% | 3.41 B USD |